Stock Events

Stock Events

Kalaris Therapeutics (KLRS) Q1 2025 Earnings

7MarConfirmed

Q1 2025

-7.34

-5.81

-4.29

-2.76

Details

Expected EPS

-2.76

Actual EPS

-7.335

Surprise EPS

-4.58

Surprise Percent

+165.76%

Description

Kalaris Therapeutics (KLRS) has reported earnings of -7.335 per share for Q1 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.